BioVie requested that the SEC consent to the withdrawal of its registration statement on Form S-1, effective as of the date hereof or at the earliest practicable date hereafter. The registration statement was originally filed by the company on November 10. The company has determined to withdraw the registration statement and not pursue the public offering at this time. The registration statement has not been declared effective by the SEC and the company confirms that no securities have been sold pursuant to the registration statement.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on BIVI:
- BioVie issues letter to shareholders
- BioVie’s Alzheimer’s candidate shows potential impact in Phase 2 trial
- BioVie Announces Additional Findings from Phase 2 Alzheimer’s Disease Trial: NE3107 Appears to Impact Biomarkers of Aging-Related Disease States in Addition to Observed Reversal of Cognitive Decline in Dementia
- BioVie (NASDAQ:BIVI) Stock Surges on Positive Results from Two Phase 2 Trials
- BioVie Announces Positive Results for NE3107 in Parkinson’s and Alzheimer’s Phase 2 Trials
